ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MTEM Molecular Templates Inc

1.45
-0.035 (-2.36%)
Pre Market
Last Updated: 08:19:05
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Molecular Templates Inc MTEM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.035 -2.36% 1.45 08:19:05
Open Price Low Price High Price Close Price Prev Close
1.485
more quote information »

Recent News

Date Time Source Heading
4/09/202408:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
3/29/202408:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
3/28/202408:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
3/04/202408:11GLOBEMolecular Templates, Inc. Provides Interim Update
2/14/202420:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202416:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202417:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
1/25/202417:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202416:04EDGAR2Form 8-K - Current report
11/13/202316:13EDGAR2Form 8-K - Current report
11/13/202316:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
11/02/202316:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
11/01/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202316:12GLOBEMolecular Templates to Participate in Upcoming Investor..
10/31/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/27/202316:12EDGAR2Form 8-K - Current report
10/06/202317:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/28/202317:01EDGAR2Form 8-K - Current report
9/28/202316:11GLOBEMolecular Templates Announces the Appointment of Dr...
9/12/202317:15EDGAR2Form ARS - Annual Report to Security Holders
9/12/202317:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/12/202317:08EDGAR2Form DEF 14A - Other definitive proxy statements
8/31/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/31/202316:11EDGAR2Form 8-K - Current report
8/11/202316:12EDGAR2Form 8-K - Current report
8/11/202311:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
8/10/202309:01EDGAR2Form S-3 - Registration statement under Securities Act of..
8/10/202308:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202308:09EDGAR2Form 8-K - Current report
8/10/202308:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
8/02/202316:16EDGAR2Form 8-K - Current report
8/02/202316:11GLOBEMolecular Templates Announces Executive Leadership Changes
7/18/202311:56EDGAR2Form DEF 14A - Other definitive proxy statements
7/13/202312:48EDGAR2Form 8-K - Current report
7/13/202308:14GLOBEMolecular Templates Announces Up to $40 Million Private..
6/30/202316:31EDGAR2Form PRE 14A - Other preliminary proxy statements
6/16/202320:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring
6/01/202307:57GLOBEMolecular Templates Announces the FDA Removal of Partial..
5/26/202317:10GLOBEMolecular Templates to Present on Phase I Dose Escalation..
5/15/202316:13GLOBEMolecular Templates, Inc. Reports First Quarter 2023..

Your Recent History

Delayed Upgrade Clock